Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease by Kofink, Daniel, Muller, Steven A, Patel, Riyaz S, Dorresteijn, Jannick A N, Berkelmans, Gijs F N, de Groot, Mark C H, van Solinge, Wouter W, Haitjema, Saskia, Leiner, Tim, Visseren, Frank L J, Hoefer, Imo E, Asselbergs, Folkert W

Get full text

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective? by Berkelmans, Gijs F N, Greving, Jacoba P, van der Graaf, Yolanda, Visseren, Frank L J, Dorresteijn, Jannick A N

Get full text

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort by Sharif, Shahnam, Groenwold, Rolf H. H., Graaf, Yolanda, Berkelmans, Gijs F. N., Cramer, Maarten J., Visseren, Frank L. J., Westerink, Jan, van Petersen, R., Dinther, B.G.F., Algra, A., van der Graaf, Y., Grobbee, D.E., Rutten, G.E.H.M., Visseren, F.L.J., de Borst, G.J., Kappelle, L.J., Leiner, T., Nathoe, H.M.

Get full text

Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice by Berkelmans, Gijs F.N., Read, Stephanie H., Gudbjörnsdottir, Soffia, Wild, Sarah H., Franzen, Stefan, van der Graaf, Yolanda, Eliasson, Björn, Visseren, Frank L.J., Paynter, Nina P., Dorresteijn, Jannick A.N.

Get full text

Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with... by Berkelmans, Gijs F N, Gudbjörnsdottir, Soffia, Visseren, Frank L J, Wild, Sarah H, Franzen, Stefan, Chalmers, John, Davis, Barry R, Poulter, Neil R, Spijkerman, Annemieke M, Woodward, Mark, Pressel, Sara L, Gupta, Ajay K, van der Schouw, Yvonne T, Svensson, Ann-Marie, van der Graaf, Yolanda, Read, Stephanie H, Eliasson, Bjorn, Dorresteijn, Jannick A N

Get full text

Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals by McKay, Ailsa J, Gunn, Laura H, Ference, Brian A, Dorresteijn, Jannick A N, Berkelmans, Gijs F N, Visseren, Frank L J, Ray, Kausik K

Get full text

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis by Berkelmans, Gijs F.N., van der Graaf, Yolanda, Dorresteijn, Jannick A.N., de Borst, Gert Jan, Cramer, Maarten J., Kappelle, L. Jaap, Westerink, Jan, Visseren, Frank L.J.

Get full text

SPRINT trial: It’s not just the blood pressure by Berkelmans, Gijs FN, Visseren, Frank LJ, Jaspers, Nicole EM, Spiering, Wilko, van der Graaf, Yolanda, Dorresteijn, Jannick AN

Get full text